- Research article
- Open Access
Damage of Streptococcus mutans biofilms by carolacton, a secondary metabolite from the myxobacterium Sorangium cellulosum
© Kunze et al; licensee BioMed Central Ltd. 2010
Received: 16 February 2010
Accepted: 26 July 2010
Published: 26 July 2010
Streptococcus mutans is a major pathogen in human dental caries. One of its important virulence properties is the ability to form biofilms (dental plaque) on tooth surfaces. Eradication of such biofilms is extremely difficult. We therefore screened a library of secondary metabolites from myxobacteria for their ability to damage biofilms of S. mutans.
Here we show that carolacton, a secondary metabolite isolated from Sorangium cellulosum, has high antibacterial activity against biofilms of S. mutans. Planktonic growth of bacteria was only slightly impaired and no acute cytotoxicity against mouse fibroblasts could be observed. Carolacton caused death of S. mutans biofilm cells, elongation of cell chains, and changes in cell morphology. At a concentration of 10 nM carolacton, biofilm damage was already at 35% under anaerobic conditions. A knock-out mutant for comD, encoding a histidine kinase specific for the competence stimulating peptide (CSP), was slightly less sensitive to carolacton than the wildtype. Expression of the competence related alternate sigma factor ComX was strongly reduced by carolacton, as determined by a pcomX luciferase reporter strain.
Carolacton possibly interferes with the density dependent signalling systems in S. mutans and may represent a novel approach for the prevention of dental caries.
Biofilms that harbour pathogenic bacteria are a serious health problem of increasing importance. They have been implicated in many persistent and chronic diseases such as cystic fibrosis, endocarditis, and infections caused by biofilms growing on incorporated foreign materials, e.g. stents, indwelling catheters, bone implants, and artificial valves [1–5]. Dental caries and periodontal diseases, which are among the most common bacterial infections in humans, are caused by biofilms known as dental plaque that result from microbial colonization of the tooth surface or the subgingival margin [6, 7].
Eradication of biofilm bacteria by conventional antibiotic therapy is notoriously difficult or almost impossible due the much higher resistance level of the cells that is partially caused by the barrier effect of the exopolysaccharide matrix, and more importantly by profound genetic and metabolic adaptations of the cells to a sessile mode of growth [4, 8, 9]. It has been estimated that bacteria embedded in biofilms are more than 1000-fold less susceptible to the effects of commonly used antimicrobial compounds than are their planktonic counterparts [8, 10, 11]. Thus novel strategies for battling clinically relevant biofilms are urgently needed, particularly if one takes into consideration that biofilm-forming bacteria account for about two-thirds of human bacterial infections . Quorum sensing systems might be promising targets in treating biofilm-induced infections. These intercellular communication mechanisms are mediated by extracellular small signalling molecules (autoinducers) and coordinate population wide gene expression of e.g. virulence factors such as biofilm formation in a cell-density-dependent manner [2, 12]. The development of anti-quorum-sensing drugs that specifically attenuate virulence might represent an attractive alternative to conventional antibiotic therapy, particularly considering the fact that these antibacterial compounds are less likely to induce the development of resistant bacteria.
Such a "proof of concept" has already been provided by mimics of the acylated homoserine lactone signalling molecules, such as synthetic derivatives of natural furanones, which are able to inhibit in vivo biofilm development of Pseudomonas aeruginosa , and when covalently bound to surfaces also those of Staphylococcus epidermidis . Moreover the quorum-sensing RNA III inhibiting peptide was shown to inhibit in vivo biofilm formation of Staphylococcus aureus . However none of the quorum sensing blockers tested in animal models so far was suitable for human use.
Our project is aimed at finding new inhibitors of biofilm formation of the Gram-positive facultative anaerobic bacterium S. mutans. Among more than 500 bacterial species found in dental plaque [16–18] S. mutans is considered to be the principal pathogen causing human dental caries . While metabolising dietary carbohydrates, S. mutans rapidly produces acid endproducts lowering the pH to approximately pH 3.5 resulting in demineralisation of the dental enamel and caries formation [20–22]. Moreover S. mutans can be a cause of subacute infective endocarditis [19, 23].
We focused in our search for biofilm inhibitors on our collection of secondary metabolites from myxobacteria. They are ubiquitous Gram-negative soil bacteria characterized by their ability to glide in swarms, as well as by their complex life cycle that upon starvation culminates in the formation of multicellular fruiting bodies, containing dormant myxospores . The complexity of their social behaviour and morphogenetic potential is reflected in their large genomes (9-13 Mbp), some of which, e.g. Sorangium cellulosum So ce56  have been sequenced. The overrepresentation of genes involved in secondary metabolism also explains the capability of myxobacteria to produce such a high number of potentially useful low molecular weight compounds. Over the past 25 years, more than 100 secondary metabolites with more than 450 structural variants have been isolated from myxobacteria at the HZI. Most of these compounds turned out to be new and show novel unrelated structures as well as different biological activities with interesting mechanisms of action [24, 26, 27]. About a third of these myxobacterial compounds however did not show any biological or biochemical effect in our test battery, which until now predominantly focused at killing or inhibiting microbial growth. It should be pointed out that especially these compounds are of interest in exploring new targets.
Effect of carolacton on planktonic growth of bacteria and on eukaryotic cells
Carolacton has been reported to be inactive in standard bacterial growth inhibition tests using suspended (planktonic) cultures of Gram positive and Gram negative test strains  at least up to the highest tested concentration of 40 μg/mL (85 μM) . The only sensitive strain was E. coli strain tolC (MIC 0.006 μg/ml) which is characterized by a defect in the TolC protein, a component of a multidrug efflux pump located in the outer membrane , making it hypersensitive to antibiotics. A minor antifungal activity (at 16 - 20 μg/mL) has been described against various filamentous fungi, e.g. Aspergillus niger, Phytium debaryanum, and Sclertina sclerotiorum . Because of our biofilm screening results (see below) we determined the antibiotic activity of carolacton against S. mutans UA159 grown in planktonic culture. Carolacton only weakly inhibited growth under both aerobic and anaerobic conditions (MIC >106 μM) as determined in a conventional serial dilution assay. The turbidity of cultures (OD620) after 18-24 hours of incubation was reduced by 10-25% at concentrations of carolacton between 26.6 and 106 μM, respectively. Microscopical analysis showed that carolacton induced longer cell chains (see below), which might have contributed to the reduction in OD620.
Carolacton showed no acute toxicity in cell culture assays with L929 mouse fibroblasts. After 18 hours of incubation no inhibition of the metabolic activity of the cells was indicated by an MTT assay up to the highest tested concentration (79 μM). In all experiments the level of cytoplasmic histone-associated DNA fragments was below 1% of the positive control, thus no sign of apoptosis could be observed (again up to the highest tested concentration of 79 μM).
Effect of carolacton on cell morphology and viability of S. mutans
Quantification of S. mutans biofilm damage by carolacton
Therefore, we used the LIVE/DEAD BacLight bacterial viability staining as a sensitive and fast method for quantifying the effect of carolacton on biofilm viability of S. mutans. Biofilm damage was calculated as the ratio of green versus red fluorescence of the biofilm cells normalized against the untreated control. This parameter is indicative of the membrane integrity of the cells, since the red fluorescing dye can only enter cells with damaged membranes. For S. mutans, a calibration curve using isopropyl alcohol-killed and live cells in varying proportions resulted in a linear correlation between the ratio of green to red fluorescence and the amount of live cells (data not shown). For carolacton treated cells, Figure 3 shows that the extent of biofilm damage calculated from fluorescence staining was much smaller than that obtained by CFU counting. Thus, the green/red ratio of fluorescence is a conservative estimate of biofilm damage in S. mutans.
Dose-dependent damage of biofilms of S. mutans by carolacton
Time course of biofilm damage by carolacton
Membrane damage of the biofilm cells, determined by the LIVE/DEAD BacLight fluorescence staining method by staining with both SYTO9 (green) and propidium iodide (red), was calculated as the reduction of the green/red fluorescence ratio in biofilms grown with carolacton relative to untreated controls and is shown in Figure 5B for three independent experiments. It shows a similar pattern. Biofilm damage was small during the first 6 h, increased rapidly until about 8.5 or 12.25 h, respectively and then remained stable or increased more slowly till the end of the experiment after 24 hours. The curves for the two concentrations of carolacton tested were very similar, as expected from the concentration range of carolacton activity determined previously (Figure 4). The maximum reduction of the relative green/red fluorescence ratio was between 47% and 69% reflecting the dynamic process of biofilm growth. The pH dropped from pH 7.8 to pH 4.3 (24 h of growth), but there was no difference in controls and carolacton treated cultures. To summarize, the data show that carolacton temporarily reduced the total amount of biofilm cells, indicated by staining with the green fluorescent dye alone, during the period of maximum biofilm growth (Figure 5A). Most importantly, carolacton strongly reduced the viability of cells within the biofilm, determined by the reduction of the relative proportion of green to red fluorescence, throughout 24 h of biofilm development but mainly during the period of maximum biofilm growth and thereafter, while little reduction of viability was observed during the initial hours of biofilm growth (Figure 5B).
Investigation of the effect of carolacton on S. mutans biofilms by confocal laser scanning microscopy
Effect of carolacton on biofilms of quorum sensing negative mutants
S. mutans utilizes a density-dependent quorum sensing signalling system to regulate the expression of virulence factors, including biofilm formation. It involves an excreted autoinducer, the competence stimulating peptide (CSP) encoded by comC, which is detected by a two-component signal transduction system comprising the histidine kinase ComD and the response regulator ComE [34–38].
Thus, the comD knockout mutant was slightly less sensitive to carolacton than the wildtype. This could indicate that carolacton interferes with the membrane bound histidine kinase ComD. However, since the comC and comE mutants were just as sensitive for carolacton as the wildtype, and since there was still considerable activity of carolacton against the comD mutant, other mechanisms must be more important.
Influence of carolacton on a pcomX luciferase reporter strain
Dental caries, gingivitis, and periodontal diseases, which may develop as a consequence of dental plaque formation, are among the most common bacterial infections in humans. Eradication of cariogenic bacteria within dental plaque is notoriously difficult and therefore new drugs and drug applications are constantly being tested. In this study we successfully explored the possibility to use secondary metabolites from a group of soil bacteria producing diverse novel structures with a large spectrum of mechanisms of action, as inhibitors of biofilms of S. mutans, a bacterium which plays a key role in dental biofilm formation and dental caries. One such compound, carolacton, proved to strongly disturb biofilm formation of S. mutans.
Carolacton has been isolated from a myxobacterium of the species S. cellulosum, and was among the substances which were not developed further because it was "inactive", e.g. showed no significant antibiotic or antifungal activity nor acute cytotoxicity. The new biofilm screen described here resulted in the discovery of a promising biological activity for carolacton. Our study clearly demonstrates that carolacton showed high antimicrobial activity against biofilms of S. mutans, while planktonic growth of bacteria, including S. mutans, was only slightly affected. Thus, carolacton appears to target a mechanism specific for biofilm development of S. mutans.
The data show that in biofilms carolacton causes membrane damage and cell death as well as morphological changes, e.g. elongated cells, increased chain length and bulging. Total biofilm mass was only temporarily reduced during the first 12 h of biofilm growth, but not in the later stages under the conditions tested here. The dose-response curve of the activity of carolacton showed a very low threshold concentration of 10 nM and no substantial increase of activity above this concentration, suggesting that it acts as a trigger/inhibitor of a signalling pathway. We hypothesized that carolacton might induce cell death and possibly reduced acid tolerance (resulting in elongated or bulged cells) by interfering with the competence and stress related cell-cell signalling network in S. mutans. This network is comprised in part of pheromone CSP (the comCDE system)-dependent and CSP independent components which respond to environmental signals [40, 42, 43]. CSP can trigger cell death at high concentrations by inducing an auto-active intracellular bacteriocin, CipB, in a fraction of the biofilm cells . In some ways the activity of carolacton is similar to that of CSP at concentrations above those that induce competence. CSP and carolacton both induce balloon like cell morphology, and cell death in about 50% of the biofilm cells, an effect which was not increased by increasing their concentration . Unlike carolacton (see below), CSP activity is exclusively mediated through comDE, i.e. the comC and comD null mutants were insensitive to CSP . We studied the response of mutants lacking functional comC, comD or comE to carolacton. Only the comD mutant showed slightly less biofilm damage than the wildtype. The histidine kinase ComD induces transcription of the "early" competence genes, among them 5 mutacins and the sigma factor ComX. ComX then triggers the expression of the "late" competence genes. The lack of ComD controlled synthesis of mutacins, among them an autolysin, and their corresponding immunity proteins and membrane transporters, and the reduced expression of the late competence genes, including stress tolerance genes, in the ΔcomD mutant strain, apparently makes this mutant more resistant to carolacton, although only to a small extent.
However, other mechanisms must be operating as well, since this mutant was still damaged by about 40%. Fourteen two-component systems consisting of a histidine kinase (HK) and a response regulator (RR) have been identified in S. mutans [44, 45]. In addition to ComDE, genetic competence is also mediated through VicRK (HK/RR1) , the CiaHR (HK/RR2) , and the HK/RR11 [36, 47]. Moreover, immunity against autolysis is controlled in a density dependent way by LiaSR (formerly HK/RR11). Carolacton might therefore act not only or not primarily on ComD, but also on some of the other two component systems of S. mutans.
To obtain further insights into the possible mode of action of carolacton, we then studied its effect on the expression of ComX, the alternate sigma factor of S. mutans which is induced by CSP and stress and controls not only genetic competence , but also stress related traits. Altogether 240 genes are directly or indirectly controlled by comX . The data show that indeed the expression of pcomX after induction by CSP is strongly inhibited by carolacton, suggesting that carolacton interferes with the ComX related signalling network in S. mutans. The alternate sigma factor ComX controls the expression of the so-called "late" competence genes. They comprise the complete cellular machinery for uptake and processing of DNA, representing the essential mechanism for genetic competence. In addition, stress related phenotypes are also controlled by comX . Competence is not only induced by the ComDE mediated signaling cascade, but several other two-component systems and response regulators are also involved, e.g. CiaH, HtrA , HK11/RR11 , and the VicRK system . Therefore, CSP related and CSP independent signaling cascades exist for inducing competence and stress tolerance, which however all rely on the late competence genes and thus converge on comX induction. A reduction in the expression of comX by carolacton after CSP stimulation could therefore be caused by a direct interaction of carolacton with ComD, with CSP, or with the binding of CSP to ComD, resulting in an impaired signaling cascade and reduced comX expression. Since a ΔcomD mutant, which cannot respond to CSP through ComD, shows only slightly reduced sensitivity to carolacton, this scenario is not supported by the data. It appears more likely that one of the other two-component systems involved in competence regulation or stress response is inhibited by carolacton, and that this inhibition is relayed to comX via the specific signaling cascade. The comD gene was shown to be differentially expressed in a RR11 mutant , and therefore an indirect effect of carolacton on comD expression through one of the other two-component systems is also possible.
Other mechanisms could also contribute to cell death in a growth dependent way. For example, the gene atlA was discovered to decrease autolysis and cause elongated cell chains, thus affecting biofilm formation [49, 50]. Interestingly, the ΔcomD mutant, which is unable to induce comX expression after CSP stimulation, was slightly less sensitive to carolacton, but carolacton reduced the CSP induced comX expression, which appears to be contradictory. However, the sigma factor comX and the histidine kinase comD are connected through a complex signaling network which receives input from several histidine kinases as well as additional regulators. The experimental conditions analysed here, e.g. knock-out of comD, and determination of comX expression after CSP stimulation, both are highly artificial. Thus, since the mechanism of carolacton is not known, the causal relationship between them cannot be inferred from the data presented here. ComD plays apparently only a small role for the effect of carolacton. If one or several of the other thirteen two-component systems of S. mutans are affected by carolacton, this could lead to the observed result with the highly sensitive pcomX reporter strain. A transcriptome analysis would be needed to determine the effect of carolacton on comD and comX expression as well as on the other two-component systems of S. mutans under "natural" conditions, d.h. without additional stimulation by CSP.
CSP has been shown to inhibit biofilms and to cause elongated cells at high concentrations . Antibacterial activity of other peptides has been tested against S. mutans, but relatively high concentrations are required . Killing activity was therefore enhanced by a combination of inhibitory peptides with desinfectants . Killing activity has also been enhanced by constructing synthetic peptides consisting of two inhibitory domains . In another approach, the cytotoxic effect of inhibitory peptides was combined with the specificity of the ComD receptor, resulting in so called STAMPs (targeted antimicrobial peptides). Such STAMPs were constructed by fusing an inhibitory peptide with a targeting domain derived from CSP . By contrast, carolacton is structurally unrelated to peptide pheromones. Proof of principle for using chemically unrelated compounds as inhibitors has been obtained for the acylated homoserine lactone based quorum sensing system of Gram negative bacteria .
Bacterial signalling systems have emerged in recent years as attractive targets for antimicrobial therapy. The discovery of a compound damaging S. mutans biofilms which might be targeting one or several of its two-component systems involved in regulating biofilm formation, autolysis and stress tolerance could provide a novel approach for future therapeutic strategies to prevent dental plaque related diseases with only minimal impact on the normal microbial flora.
Bacterial strains and culture conditions
S. mutans wild-type strain UA159 (ATCC 700610) and its knockout mutants defective in the quorum sensing genes comC, comD, or comE have been provided by courtesy of Prof. Dr. D. G. Cvitkovitch from the University of Toronto, Canada. The mutants were constructed by allelic replacement of the gene in question with an erythromycin resistance cassette using the PCR ligation mutagenesis strategy described in more detail in . The wild-type strain was maintained routinely on Todd-Hewitt (TH) agar plates (Difco) and liquid cultures were grown in Todd-Hewitt broth Bacto™(THB). For cultivation of the mutants, erythromycin was added at 10 μg per ml to the media. For biofilm growth, THB was supplemented with 0.5% sucrose (THBS). Incubation was at 37°C without agitation under aerobic (with 10% CO2) or anaerobic (80% N2, 10% H2, 10% CO2) conditions. For anaerobic growth, the medium was flushed with nitrogen before use. Escherichia coli DH5α was used as cloning strain and routinely cultured in Luria Bertani (LB, Carl-Roth, Karlsruhe, Germany) medium at 37°C. E. coli strains carrying plasmids were selected with 50 μg ml-1 spectinomycin.
Inhibition of planktonic growth and determination of cytotoxicity
The minimal inhibitory concentration of carolacton on planktonic growth of S. mutans UA159 was determined with the conventional serial two-fold dilution method in 96-well microtiter plates (200 μl/well). As inoculum 1 × 106 cells/ml were used, and carolacton was dissolved in MeOH, producing concentrations in the cultures of not more than 5%. Incubation was for 24 hours at 37°C under both anaerobic and aerobic conditions. Optical density (OD) measurements at 620 nm were performed using a Wallac Victor3™1420 Multilabel Counter (Perkin-Elmer Life Sciences). Acute cytotoxicity against L929 mouse cells (connective tissue, ATCC CCL 1) was determined using an MTT assay as reported . Cytoplasmic histone-associatd DNA fragments were measured with the Cell Death Detection ELISA kit from Roche Diagnostic to determine apoptosis induction in L929 cells. Cells were inoculated at 10000 cells/well in a 96-well plate, grown to sub-confluence for 2 days and then incubated with different concentrations of carolacton for 18 hours.
Biofilm formation was induced in 96-well polystyrene flat-bottom microtiter plates (Greiner bio-one, μClear-Plate Black). Overnight cultures of S. mutans UA159 and its corresponding mutants grown anaerobically in THB (if necessary in the presence of 10 μg/ml erythromycin) were diluted to an OD620 of 0.01-0.03 in fresh THB with the addition of 0.5% (w/v) sucrose. Aliquots thereof (95 μl) were distributed into microtiter plate wells, which contained 5 μl of different concentrations of a test compound or alternatively 5 μl of methanol as control. All measurements were done in triplicate. The microtiter plates were incubated at 37°C without shaking under anaerobic conditions for 24 h unless indicated otherwise.
Determination of cell viability by counting colony forming units (CFU)
Samples were serially diluted in 0.85% NaCl, and two to three appropriate dilutions were plated in triplicate onto TH agar and incubated anaerobically at 37°C for 2 days before counting. For enumerating biofilm CFUs, biofilms were scraped off from the bottom of the wells using pipette tips, resuspended in 0.85% NaCl, vortexed for 1 min and treated as above.
LIVE/DEAD Bac Light bacterial viability staining
Biofilms were analysed using the LIVE/DEAD Bac Light bacterial viability staining kit L13152 (Invitrogen, Molecular Probes, Inc. Eugene, OR, USA) according to the manufacturer's instructions. The kit consists of two stains, propidium iodide and SYTO9, which both stain nucleic acids. When used alone, green fluorescing SYTO9 generally labels all bacteria in a population, whereas red fluorescing propidium iodide only penetrates bacteria with damaged membranes, causing a reduction in the SYTO9 stain fluorescence. Thus with an appropriate mixture of the SYTO9 and Ppropidium iodide stains, bacteria with intact membranes stain fluorescent green, and bacteria with damaged membranes stain fluorescent red. Staining of biofilms was usually carried out for 15 min in the dark at room temperature with 100 μl of a 1:1 mixture of the two dye components. In some experiments biofilms were also stained exclusively with the green fluorescing component SYTO9. To remove planktonic and loosely bound bacteria the biofilms were carefully washed before staining with 100 μl of 0.85% NaCl. Fluorescence was measured in a microtiter plate reader (Wallac Victor3™1420 Multilabel Counter, Perkin-Elmer Life Sciences) equipped with detectors and filter sets for monitoring red (630 nm) and green (535 nm) fluorescence. Results are expressed as reduction of the ratio of green/red fluorescence compared to untreated controls.
Construction of a pcomX luciferase reporter strain and luciferase assay
For the construction of the luciferase reporter strains, the advanced firefly luciferase gene was amplified using Pfu polymerase from plasmid pHL222 (Lößner et al. , unpuplished) by utilisation of primers lucF (5'ATATACCATGG AAGACGCCAAAAAC) and lucR (5'-AAAAAAACTAGT TTATGCTAGTTATTGCTCAGCGG-3') bearing restriction sites (bold) for NcoI and SpeI. The amplicon was cloned into the suicide vector pFW5  via the NcoI and SpeI sites to generate plasmid pALEC15. A fragment comprising approximately 1 kb of sequence upstream of the comX start codon was PCR-amplified using genomic DNA of S. mutans UA159 as template
(Primer pair P102_1997 For (5'-AAAAAAACCATGG TCCAAAAATAAGTGACTAAGG-3') and P103_1997 Rev (5'-AAAAAAACCATGG CTATTACGATGACCTCCTTT-3')). Restriction sites for NcoI (bold) were introduced via the 5' termini of the PCR primers. The digested amplicon was ligated into the vector pALEC15 cut with the same enzyme and containing the promoterless luciferase gene and a spectinomycin resistance cassette. Constructs confirmed by PCR and sequencing were transformed in S. mutans UA159 according to the method of Li et al  and chromosomally integrated via single crossover homologous recombination. Transformed cells were plated on selective THY agar with spectinomycin (600 μg/ml) and single colonies were picked. For the confirmation of the expected integration a PCR was performed and the identity of the integrated DNA was confirmed by sequencing In addition the inductivity of clones with CSP was tested as positive control . The luciferase assay was performed in optical 96 well polystyrene white microtiter plates (Nunc) as described by Loimaranta et al. . Briefly, overnight cultures of the pcomX-luciferase reporter strain of S. mutans were diluted 1:10 in fresh THB-media (pH 6.5) and grown for one hour at 37°C under anaerobic conditions. Aliquots of 100 μl of cells were taken as reference sample before CSP-induction. Subsequently 2 μM carolacton and/or 200 nM CSP were added to the cells and samples were taken at different timepoints post induction. The production of luciferase was stopped by an immediate cold-shock and an incubation on ice. In addition the luminescence of untreated cells was also determined. For the assay 100 μl of the samples were diluted with 100 μl of glucose-containing buffer (2% glucose, 0.9 mM ATP, 25 mM tricine, 5 mM MgSO4, 0.5 mM EDTA, 0.5 mM DTT to ensure sufficient levels of intracellular ATP. After incubation for 10 minutes at room temperature 100 μl of 360 μM D-luciferin in 20 mM tricine was added through a dispenser and luminescence was measured in a Victor X-Light™1420 Luminescence Plate Reader (Perkin Elmer Life Sciences). For an appropriate comparison of the different samples the luminescence was normalized against the optical density at 620 nm wavelength. The mean of at least three independent biological samples was determined, and each experiment was repeated at least twice.
For the determination of pcomX controlled luciferase activity in biofilms, an overnight culture of the S. mutans pcomX-luciferase reporter strain was diluted in fresh THBS-medium to an OD600 = 0,05. The biofilms were grown in an polystyrene 96 well microtiter-plate (Greiner BioOne, Frickenhausen, Germany) containing 200 μl of cell culture per well. After 3,5 h of growth (37°C, anaerobic conditions) the supernatant was completely removed and replaced with fresh THBS-medium containing 200 nM CSP and/or 2 μM carolacton. Untreated cells were used as reference samples. At least three wells were used as replicates for each condition tested. Samples were harvested at different time points following supplementation of CSP and/or carolacton using a rubber scraper. Scraped off cells were resuspended in 200 μl of THBS and the luciferase assay was performed as described above.
Confocal Laser Scanning Microscopy
Biofilms developed on half area 96-well polystyrene flat-bottom microtiter plates for 12 or 23 h in triplicate and stained with the LIVE/DEAD BacLight viability kit (see above) were observed using an Olympus FlowView 1000 (Olympus, Tokyo, Japan) confocal laser scanning microscope. To acquire green ("live") and red ("dead") fluorescence, respectively, a laser excitation at 488 nm (Ar laser) and 561 nm (He laser) and emission filters at 500 - 545 nm and 580 - 680 nm were used. Image data were subsequently processed with the Imaris software (Bitplane AG, Zürich, Switzerland).
The authors thank Prof. Dr. D.G. Cvitkovitch (University of Toronto, Canada) for providing the S. mutans strains, Birte Engelhardt and Bettina Elxnat for skillful technical assistance, Dr. Florenz Sasse for performing mammalian cell culture tests, Dr. Helena Sztajer for many helpful suggestions and members of the chemical pipeline for providing secondary metabolites from myxobacteria.
- Costerton JW, Stewart PS, Greenberg EP: Bacterial biofilms: a common cause of persistent infections. Science. 1999, 284: 1318-1322. 10.1126/science.284.5418.1318.View ArticlePubMedGoogle Scholar
- Costerton JW, Montanaro L, Arciola CR: Bacterial communications in implant infections: a target for an intelligence war. Int J Artif Organs. 2007, 30: 757-763.PubMedGoogle Scholar
- Lynch AS, Robertson GT: Bacterial and fungal biofilm infections. Annu Rev Med. 2008, 59: 415-428. 10.1146/annurev.med.59.110106.132000.View ArticlePubMedGoogle Scholar
- Hall-Stoodley L, Costerton JW, Stoodley P: Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol. 2004, 2: 95-108. 10.1038/nrmicro821.View ArticlePubMedGoogle Scholar
- Parsek MR, Singh PK: Bacterial biofilms: an emerging link to disease pathogenesis. Annu Rev Microbiol. 2003, 57: 677-701. 10.1146/annurev.micro.57.030502.090720.View ArticlePubMedGoogle Scholar
- Kolenbrander PE, Palmer RJ, Rickard AH, Jakubovics NS, Chalmers NI, Diaz PI: Bacterial interactions and successions during plaque development. Periodontol 2000. 2006, 42: 47-79. 10.1111/j.1600-0757.2006.00187.x.View ArticlePubMedGoogle Scholar
- Kolenbrander PE: Oral microbial communities: biofilms, interactions, and genetic systems. Annu Rev Microbiol. 2000, 54: 413-437. 10.1146/annurev.micro.54.1.413.View ArticlePubMedGoogle Scholar
- Stewart PS, Costerton JW: Antibiotic resistance of bacteria in biofilms. Lancet. 2001, 358: 135-138. 10.1016/S0140-6736(01)05321-1.View ArticlePubMedGoogle Scholar
- Donlan RM, Costerton JW: Biofilms: survival mechanisms of clinically relevant micro-organisms. Clin Microbiol Rev. 2002, 15: 167-193. 10.1128/CMR.15.2.167-193.2002.PubMed CentralView ArticlePubMedGoogle Scholar
- Fux CA, Costerton JW, Stewart PS, Stoodley P: Survival strategies of infectious biofilms. Trends Microbiol. 2005, 13: 34-40. 10.1016/j.tim.2004.11.010.View ArticlePubMedGoogle Scholar
- Olson ME, Ceri H, Morck DW, Buret AG, Read RR: Biofilm bacteria: formation and comparative susceptibility to antibiotics. Can J Vet Res. 2002, 66: 86-92.PubMed CentralPubMedGoogle Scholar
- Miller MB, Bassler BL: Quorum sensing in bacteria. Annu Rev Microbiol. 2001, 55: 165-199. 10.1146/annurev.micro.55.1.165.View ArticlePubMedGoogle Scholar
- Hentzer M, Wu H, Andersen JB, Riedel K, Rasmussen TB, Bagge N: Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors. EMBO J. 2003, 22: 3803-3815. 10.1093/emboj/cdg366.PubMed CentralView ArticlePubMedGoogle Scholar
- Hume EB, Baveja J, Muir B, Schubert TL, Kumar N, Kjelleberg S: The control of Staphylococcus epidermidis biofilm formation and in vivo infection rates by covalently bound furanones. Biomaterials. 2004, 25: 5023-5030. 10.1016/j.biomaterials.2004.01.048.View ArticlePubMedGoogle Scholar
- Anguita-Alonso P, Giacometti A, Cirioni O, Ghiselli R, Orlando F, Saba V: RNAIII-inhibiting-peptide-loaded polymethylmethacrylate prevents in vivo Staphylococcus aureus biofilm formation. Antimicrob Agents Chemother. 2007, 51: 2594-2596. 10.1128/AAC.00580-06.PubMed CentralView ArticlePubMedGoogle Scholar
- Kroes I, Lepp PW, Relman DA: Bacterial diversity within the human subgingival crevice. Proc Natl Acad Sci USA. 1999, 96: 14547-14552. 10.1073/pnas.96.25.14547.PubMed CentralView ArticlePubMedGoogle Scholar
- Aas JA, Paster BJ, Stokes LN, Olsen I, Dewhirst FE: Defining the normal bacterial flora of the oral cavity. J Clin Microbiol. 2005, 43: 5721-5732. 10.1128/JCM.43.11.5721-5732.2005.PubMed CentralView ArticlePubMedGoogle Scholar
- Paster BJ, Boches SK, Galvin JL, Ericson RE, Lau CN, Levanos VA: Bacterial diversity in human subgingival plaque. J Bacteriol. 2001, 183: 3770-3783. 10.1128/JB.183.12.3770-3783.2001.PubMed CentralView ArticlePubMedGoogle Scholar
- Ajdic D, McShan WM, McLaughlin RE, Savic G, Chang J, Carson MB: Genome sequence of Streptococcus mutans UA159, a cariogenic dental pathogen. Proc Natl Acad Sci USA. 2002, 99: 14434-14439. 10.1073/pnas.172501299.PubMed CentralView ArticlePubMedGoogle Scholar
- Diaz PI, Chalmers NI, Rickard AH, Kong C, Milburn CL, Palmer RJ: Molecular characterization of subject-specific oral microflora during initial colonization of enamel. Appl Environ Microbiol. 2006, 72: 2837-2848. 10.1128/AEM.72.4.2837-2848.2006.PubMed CentralView ArticlePubMedGoogle Scholar
- Hamada S, Slade HD: Biology, immunology, and cariogenicity of Streptococcus mutans. Microbiol Rev. 1980, 44: 331-384.PubMed CentralPubMedGoogle Scholar
- Loesche WJ: Role of Streptococcus mutans in human dental decay. Microbiol Rev. 1986, 50: 353-380.PubMed CentralPubMedGoogle Scholar
- Mitchell TJ: The pathogenesis of streptococcal infections: from tooth decay to meningitis. Nat Rev Microbiol. 2003, 1: 219-230. 10.1038/nrmicro771.View ArticlePubMedGoogle Scholar
- Reichenbach H: The ecology of the myxobacteria. Environ Microbiol. 1999, 1: 15-21. 10.1046/j.1462-2920.1999.00016.x.View ArticlePubMedGoogle Scholar
- Schneiker S, Perlova O, Kaiser O, Gerth K, Alici A, Altmeyer MO: Complete genome sequence of the myxobacterium Sorangium cellulosum. Nat Biotechnol. 2007, 25: 1281-1289. 10.1038/nbt1354.View ArticlePubMedGoogle Scholar
- Reichenbach H: Myxobacteria, producers of novel bioactive substances. J Ind Microbiol Biotechnol. 2001, 27: 149-156. 10.1038/sj.jim.7000025.View ArticlePubMedGoogle Scholar
- Reichenbach H, Hofle G: Discovery and development of the epothilones: a novel class of antineoplastic drugs. Drugs R D. 2008, 9: 1-10. 10.2165/00126839-200809010-00001.View ArticlePubMedGoogle Scholar
- Höfle G: Isolation, Structure Elucidation and Chemical Modification of New Biologically Active Secondary Metabolites. Scientific Annual Report of the GBF. Edited by: Walsdorff H-J. 1998, 101-Google Scholar
- Kunze B, Wagner-Dobler I, Irschik H, Steinmetz H: Pharmaceutical composition effective against biofilms. 2009, PCT/EP2008/061832[WO2009/030773 A1]Google Scholar
- Jansen R, Irschik H, Huch V, Schummer D, Steinmetz H, Bock M: Carolacton - a Macrolide Ketocarbonic Acid Preventing Biofilm Formation by the Caries- and Endocarditis-associated Bacterium Streptococcus mutans. Eur J Org Chem. 2010, 7: 1284-1289. 10.1002/ejoc.200901126.View ArticleGoogle Scholar
- Irschik H, Jansen R, Gerth K, Hofle G, Reichenbach H: The sorangicins, novel and powerful inhibitors of eubacterial RNA polymerase isolated from myxobacteria. J Antibiot (Tokyo). 1987, 40: 7-13.View ArticleGoogle Scholar
- Sharff A, Fanutti C, Shi J, Calladine C, Luisi B: The role of the TolC family in protein transport and multidrug efflux. From stereochemical certainty to mechanistic hypothesis. Eur J Biochem. 2001, 268: 5011-5026. 10.1046/j.0014-2956.2001.02442.x.View ArticlePubMedGoogle Scholar
- Qi F, Kreth J, Levesque CM, Kay O, Mair RW, Shi W: Peptide pheromone induced cell death of Streptococcus mutans. FEMS Microbiol Lett. 2005, 251: 321-326. 10.1016/j.femsle.2005.08.018.View ArticlePubMedGoogle Scholar
- Li YH, Lau PC, Lee JH, Ellen RP, Cvitkovitch DG: Natural genetic transformation of Streptococcus mutans growing in biofilms. J Bacteriol. 2001, 183: 897-908. 10.1128/JB.183.3.897-908.2001.PubMed CentralView ArticlePubMedGoogle Scholar
- Li YH, Hanna MN, Svensater G, Ellen RP, Cvitkovitch DG: Cell density modulates acid adaptation in Streptococcus mutans: implications for survival in biofilms. J Bacteriol. 2001, 183: 6875-6884. 10.1128/JB.183.23.6875-6884.2001.PubMed CentralView ArticlePubMedGoogle Scholar
- Li YH, Tang N, Aspiras MB, Lau PC, Lee JH, Ellen RP: A quorum-sensing signaling system essential for genetic competence in Streptococcus mutans is involved in biofilm formation. J Bacteriol. 2002, 184: 2699-2708. 10.1128/JB.184.10.2699-2708.2002.PubMed CentralView ArticlePubMedGoogle Scholar
- Cvitkovitch DG, Li YH, Ellen RP: Quorum sensing and biofilm formation in Streptococcal infections. J Clin Invest. 2003, 112: 1626-1632.PubMed CentralView ArticlePubMedGoogle Scholar
- Kreth J, Hung DC, Merritt J, Perry J, Zhu L, Goodman SD: The response regulator ComE in Streptococcus mutans functions both as a transcription activator of mutacin production and repressor of CSP biosynthesis. Microbiology. 2007, 153: 1799-1807. 10.1099/mic.0.2007/005975-0.PubMed CentralView ArticlePubMedGoogle Scholar
- Claverys JP, Martin B, Havarstein LS: Competence-induced fratricide in streptococci. Mol Microbiol. 2007, 64: 1423-1433. 10.1111/j.1365-2958.2007.05757.x.View ArticlePubMedGoogle Scholar
- Ahn SJ, Wen ZT, Burne RA: Multilevel control of competence development and stress tolerance in Streptococcus mutans UA159. Infect Immun. 2006, 74: 1631-1642. 10.1128/IAI.74.3.1631-1642.2006.PubMed CentralView ArticlePubMedGoogle Scholar
- Aspiras MB, Ellen RP, Cvitkovitch DG: ComX activity of Streptococcus mutans growing in biofilms. FEMS Microbiol Lett. 2004, 238: 167-174.PubMedGoogle Scholar
- Perry JA, Jones MB, Peterson SN, Cvitkovitch DG, Levesque CM: Peptide alarmone signalling triggers an auto-active bacteriocin necessary for genetic competence. Mol Microbiol. 2009, 72: 905-917. 10.1111/j.1365-2958.2009.06693.x.PubMed CentralView ArticlePubMedGoogle Scholar
- Lemos JA, Burne RA: A model of efficiency: stress tolerance by Streptococcus mutans. Microbiology. 2008, 154: 3247-3255. 10.1099/mic.0.2008/023770-0.PubMed CentralView ArticlePubMedGoogle Scholar
- Biswas I, Drake L, Erkina D, Biswas S: Involvement of sensor kinases in the stress tolerance response of Streptococcus mutans. J Bacteriol. 2008, 190: 68-77. 10.1128/JB.00990-07.PubMed CentralView ArticlePubMedGoogle Scholar
- Levesque CM, Mair RW, Perry JA, Lau PC, Li YH, Cvitkovitch DG: Systemic inactivation and phenotypic characterization of two-component systems in expression of Streptococcus mutans virulence properties. Lett Appl Microbiol. 2007, 45: 398-404. 10.1111/j.1472-765X.2007.02203.x.PubMed CentralView ArticlePubMedGoogle Scholar
- Senadheera MD, Guggenheim B, Spatafora GA, Huang YC, Choi J, Hung DC: A VicRK signal transduction system in Streptococcus mutans affects gtfBCD, gbpB, and ftf expression, biofilm formation, and genetic competence development. J Bacteriol. 2005, 187: 4064-4076. 10.1128/JB.187.12.4064-4076.2005.PubMed CentralView ArticlePubMedGoogle Scholar
- Perry JA, Levesque CM, Suntharaligam P, Mair RW, Bu M, Cline RT: Involvement of Streptococcus mutans regulator RR11 in oxidative stress response during biofilm growth and in the development of genetic competence. Lett Appl Microbiol. 2008, 47: 439-444. 10.1111/j.1472-765X.2008.02455.x.PubMed CentralView ArticlePubMedGoogle Scholar
- Perry JA, Cvitkovitch DG, Levesque CM: Cell death in Streptococcus mutans biofilms: a link between CSP and extracellular DNA. FEMS Microbiol Lett. 2009, 299: 261-266. 10.1111/j.1574-6968.2009.01758.x.PubMed CentralView ArticlePubMedGoogle Scholar
- Ahn SJ, Burne RA: Effects of oxygen on biofilm formation and the AtlA autolysin of Streptococcus mutans. J Bacteriol. 2007, 189: 6293-6302. 10.1128/JB.00546-07.PubMed CentralView ArticlePubMedGoogle Scholar
- Shibata Y, Kawada M, Nakano Y, Toyoshima K, Yamashita Y: Identification and characterization of an autolysin-encoding gene of Streptococcus mutans. Infect Immun. 2005, 73: 3512-3520. 10.1128/IAI.73.6.3512-3520.2005.PubMed CentralView ArticlePubMedGoogle Scholar
- Padilla C, Lobos O, Hubert E, Poblete F, Navarro A, Nunez L: In vitro antibacterial activity of the peptide PsVP-10 against Streptococcus mutans and Streptococcus sobrinus with and without glycocalyx. Int J Antimicrob Agents. 2006, 27: 212-216. 10.1016/j.ijantimicag.2005.10.010.View ArticlePubMedGoogle Scholar
- Lobos O, Padilla A, Padilla C: In vitro antimicrobial effect of bacteriocin PsVP-10 in combination with chlorhexidine and triclosan against Streptococcus mutans and Streptococcus sobrinus strains. Arch Oral Biol. 2009, 54: 230-234. 10.1016/j.archoralbio.2008.11.007.View ArticlePubMedGoogle Scholar
- He J, Eckert R, Pharm T, Simanian MD, Hu C, Yarbrough DK: Novel synthetic antimicrobial peptides against Streptococcus mutans. Antimicrob Agents Chemother. 2007, 51: 1351-1358. 10.1128/AAC.01270-06.PubMed CentralView ArticlePubMedGoogle Scholar
- Eckert R, He J, Yarbrough DK, Qi F, Anderson MH, Shi W: Targeted killing of Strepto-coccus mutans by a pheromone-guided "smart" antimicrobial peptide. Antimicrob Agents Chemother. 2006, 50: 3651-3657. 10.1128/AAC.00622-06.PubMed CentralView ArticlePubMedGoogle Scholar
- Muh U, Hare BJ, Duerkop BA, Schuster M, Hanzelka BL, Heim R: A structurally unrelated mimic of a Pseudomonas aeruginosa acyl-homoserine lactone quorum-sensing signal. Proc Natl Acad Sci USA. 2006, 103: 16948-16952. 10.1073/pnas.0608348103.PubMed CentralView ArticlePubMedGoogle Scholar
- Sztajer H, Lemme A, Vilchez R, Schulz S, Geffers R, Yip CY: Autoinducer-2-regulated genes in Streptococcus mutans UA159 and global metabolic effect of the luxS mutation. J Bacteriol. 2008, 190: 401-415. 10.1128/JB.01086-07.PubMed CentralView ArticlePubMedGoogle Scholar
- Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983, 65: 55-63. 10.1016/0022-1759(83)90303-4.View ArticlePubMedGoogle Scholar
- Podbielski A, Spellerberg B, Woischnik M, Pohl B, Lutticken R: Novel series of plasmid vectors for gene inactivation and expression analysis in group A streptococci (GAS). Gene. 1996, 177: 137-147. 10.1016/0378-1119(96)84178-3.View ArticlePubMedGoogle Scholar
- Loimaranta V, Tenovuo J, Koivisto L, Karp M: Generation of bioluminescent Strepto-coccus mutans and its usage in rapid analysis of the efficacy of antimicrobial compounds. Antimicrob Agents Chemother. 1998, 42: 1906-1910.PubMed CentralPubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.